Gainers
- IMARA Inc. (NASDAQ:IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront.
- Azure Power Global Limited (NYSE:AZRE) shares jumped 35.4% to close at $4.86. Azure Power Global recently announced the resignation of Harsh Shah as CEO.
- SelectQuote, Inc. (NYSE:SLQT) rose 28.8% to close at $1.43.
- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) gained 27.7% to close at $36.40 amid post-IPO volatility.
- Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 26.6% to close at $1.43. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
- a.k.a. Brands Holding Corp. (NYSE:AKA) gained 23.7% to settle at $2.92 amid overall market strength as stocks rebound from recent weakness.
- Pingtan Marine Enterprise Ltd. (NASDAQ:PME) climbed 23.3% to close at $0.8998.
- Nutex Health, Inc. (NASDAQ:NUTX) gained 21.9% to close at $3.17.
- Molecular Templates, Inc. (NASDAQ:MTEM) rose 21.8% to close at $0.83. Molecular Templates said on August 31, it received notice from Nasdaq that the company no longer meets minimum bid price requirement.
- Reata Pharmaceuticals, Inc. (NASDAQ:RETA) jumped 21.1% to settle at $27.07.
- Amyris, Inc. (NASDAQ:AMRS) gained 19.6% to settle at $3.24.
- Latch, Inc. (NASDAQ:LTCH) jumped 19.2% to close at $1.24.
- Tupperware Brands Corporation (NYSE:TUP) gained 19.2% to settle at $8.77 amid overall market strength as stocks rebound from recent weakness.
- Vicarious Surgical Inc. (NASDAQ:RBOT) rose 18.8% to close at $4.37. Vicarious Surgical, last month, posted a Q2 loss of $0.16 per share.
- Biophytis S.A. (NASDAQ:BPTS) shares gained 18.1% to close at $1.11 after the company released topline results from its phase 2-3 COVA study evaluating Sarconeos (BIO101) in treating COVID-19-related respiratory failure.
- Glaukos Corporation (NYSE:GKOS) climbed 18.5% to close at $57.01 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety profile through 12 months.
- Coupa Software Incorporated (NASDAQ:COUP) jumped 17.9% to close at $65.82 as the company posted better-than-expected results for its second quarter and issued strong forecast for FY23. The company also announced a $100 million buyback program.
- Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares gained 17.8% to close at $3.91 after Alliance Global Partners initiated coverage on the stock with a Buy rating and a $20 price target.
- Aquestive Therapeutics, Inc. (NASDAQ:AQST) rose 17.6% to close at $1.47. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
- Seres Therapeutics, Inc. (NASDAQ:MCRB) rose 17% to close at $6.32. Seres Therapeutics announced completion of rolling BLA submission to the FDA for investigational microbiome therapeutic SER-109 for recurrent C. Difficile infection.
- SAI.TECH Global Corporation (NASDAQ:SAI) jumped 15.3% to close at $5.42.
- Sidus Space, Inc. (NASDAQ:SIDU) gained 14.7% to close at $3.05 after the company announced that it has signed a launch agreement with SpaceX for five launches, beginning in early 2023.
- GitLab Inc. (NASDAQ:GTLB) surged 14.3% to settle at $54.16 following Q2 results.
- SunPower Corporation (NASDAQ:SPWR) gained 14.4% to close at $27.37.
- Academy Sports and Outdoors, Inc. (NASDAQ:ASO) jumped 14% to close at $47.81. Academy Sports And Outdoors reported a second-quarter FY22 sales decline of 5.8% year-on-year to $1.69 billion.
- Penumbra, Inc. (NYSE:PEN) gained 13.2% to close at $185.90. Penumbra, last month, reported better-than-expected Q2 EPS and sales results.
- Baudax Bio, Inc. (NASDAQ:BXRX) rose 12.9% to close at $0.3399 after declining over 7% on Tuesday. Baudax Bio recently announced the pricing of a $6.2 million public offering.
- SolarEdge Technologies, Inc. (NASDAQ:SEDG) jumped 11.9% to close at $311.36. Shares of several solar companies at large traded higher in possible reaction to the recent signing of the Inflation Reduction Act. The European gas crisis could also be positively impacting solar stocks, as countries look for alternatives to gas.
- Tempur Sealy International, Inc. (NYSE:TPX) gained 11.6% to settle at $27.24.
- Unico American Corporation (NASDAQ:UNAM) gained 9.5% to close at $1.84.
- bioAffinity Technologies, Inc. (NASDAQ:BIAF) gained 6.7% to close at $5.75 after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit.
